Ibrutinib
PCI-32765;1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-2-propen-1-one;2-Propen-1-one,1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-;IBRUTINIB(PCI-32765);PCI32765;(R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo-[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-;PCI-32765(Ibrutinib);IBRUTINIB

Product Name: Ibrutinib

 

Synonyms: PCI-32765;1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-2-propen-1-one;2-Propen-1-one,1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-;IBRUTINIB(PCI-32765);PCI32765;(R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo-[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-;PCI-32765(Ibrutinib);IBRUTINIB

 

CAS:936563-96-1

 

MF: C25H24N6O2

 

MW: 440.5


Notice: If the compound is involved in patent protection, please do not use it for commercial purposes, and only for experimental analysis and research purposes. If it is sold to countries that constitute patent infringement, all the corresponding risks are not related to our company.




LOCATION : Home - Products - Anti-Tumor